Around the Practice

In collaboration with Urology Times ®, LUGPA offers members the opportunity to register and participate in a MONTHLY interactive virtual forum. Attendees can discuss, ask questions, submit and present cases across all GU malignancies.  The case-based format will provide the opportunity to share knowledge and best practices in managing challenging cases. This multi-disciplinary program will be co-moderated by Raoul S. Concepcion, MD (Nashville TN) and Jason Hafron, MD (Troy MI), and include discussants from urology, pathology, radiation oncology and medical oncology.

Moderators:

Raoul S. Concepcion, MD
The Comprehensive Prostate Center
Nashville, TN

Jason Hafron, MD
Michigan Institute of Urology
Troy, MI

 

UPCOMING CASE FORUMS



June 23, 2021 at 5 pm ET
Highlighting genomic testing in prostate cancer

Cases:

  • Newly diagnosed high grade, high risk PC
  • Heavily treated, mCRPC
Register here for June 23 



July 21, 2021  at 5 PM ET 

Cases:

  • BCG-Unresponsive, Non-Muscle Invasive Bladder Cancer
  • Muscle Invasive Bladder treated with neoadjuvant therapy, at cystectomy node+ disease
Register here for July 21 



August 18, 2021 5 PM ET 

Cases:

  • mCSPC treated with Xtandi/combination therapies
  • Young adult with newly diagnosed high-grade, high-risk prostate cancer
Register here for August 18


 

PAST ARCHIVE CASE FORUMS ON DEMAND:


January 20, 2021
Hear from key opinion leaders in the urology space as they discuss 2 complex cases across the multidisciplinary approach in upper tract urothelial carcinoma and an incidentally discovered renal mass.
Cases:

  • Upper Tract Urothelial Carcinoma
  • Incidentally discovered Renal mass and the role of biopsy and molecular testing

Watch On Demand Here.



February 17, 2021  
Cases:  

  • Incidentally discovered adrenal mass.
  • Localized prostate cancer, high risk disease with oligometastasis at diagnosis.

Watch On Demand Here



March 24, 2021 
Cases:

  • Penile/Urethral cancer with inguinal adenopathy
  • Non-muscle Invasive Bladder/Urothelial Cancer (NMIBC), BCG unresponsive

Watch On Demand Here  

 


 

April 21, 2021  
Cases:

  • mCRPC, failed or not tolerated docetaxel  
  • High-risk RCC following resection

 Watch On Demand Here 

 


 

May 19, 2021 

Cases:

  • PARP inhibitor for the treatment of metastatic castrate resistant prostate cancer
  • Immunotherapy monotherapy for the treatment of BCG-unresponsive non-muscle invasive bladder cancer
  • Novel hormone therapy for the treatment of non-metastatic castrate resistant prostate cancer

Watch On Demand Here 

 

 


 

Learn more about the Urology Times Around the Practice series here.